LWMNY
GSK icon

Landmark Wealth Management (New York)’s GSK GSK Stock Holding History

Landmark Wealth Management (New York)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Sell
10,481
-256
-2% -$13.5K 0.13% 109
2026
Q1 		$593K Buy
+10,737
New +$582K 0.16% 100

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Landmark Wealth Management (New York)'s GSK Position: Q2 2026 in Review

Landmark Wealth Management (New York) reduced its GSK (GSK) stake by 2.4% in Q2 2026, selling an estimated $13.5K and leaving 10,481 shares worth $549K. The position accounts for 0.13% of the portfolio, ranked #109.

Landmark Wealth Management (New York) first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $593K in Q1 2026. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Landmark Wealth Management (New York) held 10,481 shares of GSK worth $549K as of Q2 2026.
  • Landmark Wealth Management (New York) sold 256 GSK shares in Q2 2026, an estimated $13.5K.
  • GSK made up 0.13% of Landmark Wealth Management (New York)'s portfolio in Q2 2026, its #109 holding.
  • Landmark Wealth Management (New York) first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Landmark Wealth Management (New York)'s GSK position peaked at $593K in Q1 2026.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Landmark Wealth Management (New York)'s 13F filing for Q2 2026, filed 10 Aug 2026.